These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 21741498)

  • 1. Italian multicentre study for application of a diagnostic algorithm in autoantibody testing for autoimmune rheumatic disease: conclusive results.
    Bonaguri C; Melegari A; Ballabio A; Parmeggiani M; Russo A; Battistelli L; Aloe R; Trenti T; Lippi G
    Autoimmun Rev; 2011 Nov; 11(1):1-5. PubMed ID: 21741498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An italian multicenter study for application of a diagnostic algorithm in autoantibody testing.
    Bonaguri C; Melegari A; Dall'Aglio P; Ballabio A; Terenziani P; Russo A; Battistelli L; Aloe R; Camisa R; Campaniello G; Sartori E; Monica C
    Ann N Y Acad Sci; 2009 Sep; 1173():124-9. PubMed ID: 19758140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods.
    Homburger HA; Cahen YD; Griffiths J; Jacob GL
    Arch Pathol Lab Med; 1998 Nov; 122(11):993-9. PubMed ID: 9822128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a combined protocol for rational request and utilization of antibody assays improves clinical diagnostic efficacy in autoimmune rheumatic disease.
    Tampoia M; Brescia V; Fontana A; Zucano A; Morrone LF; Pansini N
    Arch Pathol Lab Med; 2007 Jan; 131(1):112-6. PubMed ID: 17227110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
    Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
    J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
    Vos PA; Bast EJ; Derksen RH
    Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of anti-ENA and anti-dsDNA antibodies using line immunoassay in systemic autoimmune diseases].
    Kim JM; Ihm CH; Sin DH; Ihm MK; Sim SC
    Korean J Lab Med; 2008 Oct; 28(5):353-61. PubMed ID: 18971616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of linear discriminant analysis in performance evaluation of extractable nuclear antigen immunoassay systems in the screening and diagnosis of systemic autoimmune rheumatic diseases.
    Pi D; de Badyn MH; Nimmo M; White R; Pal J; Wong P; Phoon C; O'Connor D; Pi S; Shojania K
    Am J Clin Pathol; 2012 Oct; 138(4):596-603. PubMed ID: 23010715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harmonization of autoimmune diagnostics with antinuclear antibody testing algorithm: approach of appropriateness and clinical relevance.
    Melegari A; Bonaguri C
    Isr Med Assoc J; 2014 Oct; 16(10):640-2. PubMed ID: 25438456
    [No Abstract]   [Full Text] [Related]  

  • 10. Testing for antibodies to ENA and to dsDNA is not indicated in FANA-negative sera.
    Manoussakis MN; Garalea KL; Tzioufas AG; Moutsopoulos HM
    Clin Rheumatol; 1988 Dec; 7(4):465-9. PubMed ID: 3073034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dense fine speckled indirect immunofluorescence pattern in an Australian population.
    Broadfoot A; Sivertsen T; Baumgart K
    Pathology; 2016 Apr; 48(3):247-50. PubMed ID: 27020500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the methods used for the detection of antinuclear antibodies].
    Berkem R; Gümüş T; Karakoç E; Acar N
    Mikrobiyol Bul; 2003; 37(2-3):171-8. PubMed ID: 14593900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficiency of different strategies to detect autoantibodies to extractable nuclear antigens.
    Almeida González D; Cabrera de León A; Rodríguez Pérez Mdel C; Brito Díaz B; González Hernández A; García García D; Vázquez Moncholi C; Aguirre Jaime A
    J Immunol Methods; 2010 Aug; 360(1-2):89-95. PubMed ID: 20600078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity.
    Ippolito A; Wallace DJ; Gladman D; Fortin PR; Urowitz M; Werth V; Costner M; Gordon C; Alarcón GS; Ramsey-Goldman R; Maddison P; Clarke A; Bernatsky S; Manzi S; Bae SC; Merrill JT; Ginzler E; Hanly JG; Nived O; Sturfelt G; Sanchez-Guerrero J; Bruce I; Aranow C; Isenberg D; Zoma A; Magder LS; Buyon J; Kalunian K; Dooley MA; Steinsson K; van Vollenhoven RF; Stoll T; Weisman M; Petri M
    Lupus; 2011 Mar; 20(3):250-5. PubMed ID: 21362750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplex assessment of non-organ-specific autoantibodies with a novel microbead-based immunoassay.
    Grossmann K; Roggenbuck D; Schröder C; Conrad K; Schierack P; Sack U
    Cytometry A; 2011 Feb; 79(2):118-25. PubMed ID: 21265005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibody detection with indirect immunofluorescence on HEp-2 cells: starting serum dilutions for systemic rheumatic diseases.
    González DA; León AC; Varela AR; García MG; Rahola Mde S; Pérez Mdel C; Hernández AG; Falcón MJ; Díaz BB
    Immunol Lett; 2011 Oct; 140(1-2):30-5. PubMed ID: 21684306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Belgian recommendations on ANA, anti-dsDNA and anti-ENA antibody testing.
    Van Blerk M; Bossuyt X; Humbel R; Mewis A; Servais G; Tomasi JP; Van Campenhout C; Van Hoovels L; Vercammen M; Damoiseaux J; Coucke W; Van de Walle P
    Acta Clin Belg; 2014 Apr; 69(2):83-6. PubMed ID: 24724745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease.
    Muro Y; Sugiura K; Morita Y; Tomita Y
    Lupus; 2008 Mar; 17(3):171-6. PubMed ID: 18372356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison between line immunoassay (LIA) and enzyme-linked immunosorbent assay (ELISA) for the determination of antibodies to extractable nuclear antigenes (ENA) with reference to other laboratory results and clinical features].
    Maclachlan D; Vogt P; Wu X; Rose L; Tyndall A; Hasler P
    Z Rheumatol; 2002 Oct; 61(5):534-44. PubMed ID: 12399881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autoantibodies].
    Ishihara Y
    Rinsho Byori; 2005 Jun; 53(6):562-9. PubMed ID: 16026086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.